CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Closed-loop tACSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05772702
NCT05772702N/ACompleted

Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression (CLACS): Single-Site Open-Label Pilot Study

Electromedical Products International, Inc.·interventional·Posted Mar 16, 2023·Updated May 29, 2025

In Brief

A clinical study evaluating Closed-loop tACS for Depression and 2 related conditions. Completed, enrolled 26 participants across 1 site.

Detailed Summary

The purpose of this research study is to study closed-loop transcranial alternating current stimulation (tACS) to determine its effects on symptoms of depression in people with major depressive disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedMar 16, 2023
Enrollment StartFeb 13, 2023
Primary CompletionApr 22, 2024
Study CompletionAug 19, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 3.3 years ago

Interventions

Closed-loop tACSdevice

Individual alpha tACS